ulcerative colitis and tirzepatide Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases Obesity and/or Diabetes: A Target Trial Emulation Five Things to Know About

Importantly, the weight loss trajectory showed continued progress throughout the study period, suggesting that longer treatment durations might yield even greater effects

Hsp90 inhibitor ganetespib sensitizes non-small cell lung cancer to radiation but has variable effects with chemoradiation

Compounded semaglutide can be used for managing chronic weight in obese (BMI of 30 or greater) and overweight (BMI of 27 or greater with at least one other weight-related condition) adults and type 2 diabetes, when used in combination with exercise and a reduced-calorie diet

Xichen Lin, PhD, Chief Scientific Officer

2025 Jul;27(7):3607-3626